Keefe, Bruyette & Woods Reiterates Buy Rating on CCAP

Keefe, Bruyette & Woods reiterated its buy rating on CCAP on June 16, 2026, setting a price target of $13. This action reaffirms the firm's positive outlook on the company's stock.

Other Institutional Activity in CCAP

Among CCAP's institutional investors, Texas County & District Retirement System held steady with 5,001,752 shares valued at about $60.77 million. Blackstone Inc. also maintained its position with 4,205,307 shares worth approximately $51.09 million. Fidelity National Financial, Inc. mirrored this holding with an identical amount of shares and value. Sun Life Financial Inc. held 2,226,308 shares worth $27.05 million. Invesco Ltd. increased its holdings by 369,270 shares to reach a total of 1,028,966 shares, valued at $12.5 million, marking a 56% increase. Ares Management LLC added 30,000 shares, ending with 546,409 shares valued at $6.64 million.

Crescent Capital BDC, Inc. Stock Up 5.8%

Shares of CCAP traded near $11.12. The stock's performance reflects its market dynamics and the broader economic environment affecting its sector.

Insider Buying and Selling at Crescent Capital BDC, Inc.

Recent insider buying activity at CCAP includes several key executives. On May 21, 2026, President Henry Chung purchased 4,500 shares at an average price of $11.45. Chief Executive Officer Jason Breaux bought 5,000 shares on May 20 at $11.19. On May 19, Steven Strandberg acquired 85,000 shares at $11.28. Additionally, Chief Financial Officer Gerhard Lombard bought 1,000 shares at $11.12 on May 18.

Analysts Set New Price Targets

On June 16, 2026, Keefe, Bruyette & Woods maintained its buy rating for CCAP with a $13 price target. Ladenburg Thalmann also maintained a buy rating on May 15, 2026, with a higher target of $15. Oppenheimer downgraded its rating but set a target of $16 on the same date. Wells Fargo maintained a hold rating with a $12 target.

About CCAP

CCAP operates within a sector that is influenced by various market factors. The company is involved in activities that position it within its industry, offering products and services aligned with its strategic goals.

Bottom Line

Keefe, Bruyette & Woods' reiteration of a buy rating on CCAP with a $13 target offers insight into the firm's confidence in the stock. Investors often track these ratings for signs of market sentiment and potential valuation changes. The reiterated rating should be viewed in the context of ongoing market analysis and investor strategy.